セッション |
検索結果は4件です。
- IF1-3-II (Keynote lecture) Prostaglandins and Non-steroidal Anti-inflammatory Drug induced Enteropathy
-
Masahiro Igarashi(Cancer Institute Hospital of JFCR^1)
Non-steroidal anti-inflammatory drug (NSAID) is known to increase the risk of small intestine and colon.The NSAID induced intestinal lesions was diagnosed by the exclusion of the other disease and str...
第94回日本消化器病学会総会 >
- IF1-3-III (Plenary presentation) Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells
-
Tatsushi Omatsu(Dept.of Inflammation and ImmunologyKyoto Prefectural University of MedicineKyotoJapan^1)
Background : Recent progress of endoscope in small intestine made us aware the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs)such as indomethacin (IND)on small intestinal mucosa. Bu...
第94回日本消化器病学会総会 >
- IF1-3-IV (Plenary presentation) Role of protease/PAR2 pathway in the pathogenesis of indomethacin-induced rats enteritis
-
Kazuhiko Uchiyama(Inflammation and ImmunologyKyoto Prefectural University of MedicineKyotoJapan^1)
(Background and Aims] NSAIDs-induced enteropathy is clinically very important but the pathologicalmechanisms have been still unclear. We have previously reported that mast cells are involved in thepat...
第94回日本消化器病学会総会 >
- IF1-3-I (Keynote lecture) Intestinal permeability and NSAID-enteropathy
-
Ingvar Bjarnason(King's College HospitalLondonUK)
The main concern with long-term ingestion of NSAIDs is their gastrointestinal side effects. The gastricside effects (dyspepsiaerosions and ulcersbleeding and perforation) of these drugs are well recog...
第94回日本消化器病学会総会 >
|